FDA Drug information
Everolimus
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Everolimus EVEROLIMUS .25 mg/1 Ascend Laboratories, LLC
- Everolimus EVEROLIMUS .25 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS .25 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS .25 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS .25 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS .5 mg/1 Ascend Laboratories, LLC
- Everolimus EVEROLIMUS .5 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS .5 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS .5 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS .5 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS .75 mg/1 Ascend Laboratories, LLC
- Everolimus EVEROLIMUS .75 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS .75 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS .75 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS .75 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 1 mg/1 Ascend Laboratories, LLC
- Everolimus EVEROLIMUS 1 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS 1 mg/1 Par Pharmaceutical, Inc.
- EVEROLIMUS EVEROLIMUS 10 mg/1 Biocon Pharma Inc.
- Everolimus EVEROLIMUS 10 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 10 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS 10 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 10 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 10 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS 10 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 10 mg/1 Teva Pharmaceuticals USA, Inc.
- Everolimus EVEROLIMUS 2 mg/1 Mylan Pharmaceuticals Inc.
- EVEROLIMUS EVEROLIMUS 2.5 mg/1 Biocon Pharma Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS 2.5 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 2.5 mg/1 Teva Pharmaceuticals USA, Inc.
- Everolimus EVEROLIMUS 3 mg/1 Mylan Pharmaceuticals Inc.
- EVEROLIMUS EVEROLIMUS 5 mg/1 Biocon Pharma Inc.
- Everolimus EVEROLIMUS 5 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 5 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS 5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 5 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS 5 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 5 mg/1 Teva Pharmaceuticals USA, Inc.
- EVEROLIMUS EVEROLIMUS 7.5 mg/1 Biocon Pharma Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Breckenridge Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Hikma Pharmaceuticals USA Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Mylan Pharmaceuticals Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Natco Pharma Limited
- Everolimus EVEROLIMUS 7.5 mg/1 Par Pharmaceutical, Inc.
- Everolimus EVEROLIMUS 7.5 mg/1 Teva Pharmaceuticals USA, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.